Invasive Aspergillosis Before HCT: Safe to Proceed?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Routine Infectious Disease Consultation Prior to an Allogeneic Hematopoietic Cell Transplant.
Portillo V, Masouridi-Levrat S, Chalandon Y, Mappoura M, Morin S, Marinosci A Open Forum Infect Dis. 2023; 10(12):ofad578.
PMID: 38088980 PMC: 10715776. DOI: 10.1093/ofid/ofad578.
References
1.
De Pauw B, Walsh T, Donnelly J, Stevens D, Edwards J, Calandra T
. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group.... Clin Infect Dis. 2008; 46(12):1813-21.
PMC: 2671227.
DOI: 10.1086/588660.
View
2.
Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J
. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis. 2009; 48(3):265-73.
DOI: 10.1086/595846.
View
3.
Marr K, Carter R, Crippa F, Wald A, Corey L
. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002; 34(7):909-17.
DOI: 10.1086/339202.
View
4.
Penack O, Tridello G, Hoek J, Socie G, Blaise D, Passweg J
. Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties. Bone Marrow Transplant. 2015; 51(3):418-23.
DOI: 10.1038/bmt.2015.237.
View
5.
Cordonnier C, Rovira M, Maertens J, Olavarria E, Faucher C, Bilger K
. Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study. Haematologica. 2010; 95(10):1762-8.
PMC: 2948103.
DOI: 10.3324/haematol.2009.020073.
View